Today: 19 July 2026
UOB share price ends higher at S$36.74 as buybacks continue — what to watch next
17 January 2026
1 min read

UOB share price ends higher at S$36.74 as buybacks continue — what to watch next

Singapore, Jan 17, 2026, 14:53 SGT — Market closed

Shares of United Overseas Bank Limited closed Friday up 0.9% at S$36.74, mirroring gains across Singapore’s big three banks as the Straits Times Index ticked up 0.3% by the close. Interactive Brokers senior economist Jose Torres pointed to “bullish sentiment” returning on Wall Street following Taiwan Semiconductor Manufacturing’s earnings, which helped steady risk appetite heading into the weekend. The Straits Times

This matters because UOB, DBS, and OCBC have a bigger influence on Singapore’s benchmark than most sectors. With the market closed until Monday, investors will use the break to assess if the recent uptick reflects global sentiment or signals a more concrete shift linked to capital returns and funding moves.

UOB’s own documentation suggests the focus is on capital management. Regular buybacks, even if modest in size each day, can help steady the stock when markets turn volatile.

After the market closed, UOB reported buying back 38,000 shares on Jan 16, paying between S$36.32 and S$36.74 each, for a total of around S$1.39 million. The bank has since cancelled those shares. According to the filing, UOB has repurchased roughly 19.2 million shares under its April 2025 mandate, accounting for about 1.15% of its issued stock.

The buyback is standard procedure, yet it remains noticeable. Traders will be keen to see if the bank maintains this pace once Singapore reopens on Monday, especially if regional bank stocks begin responding to bond yield fluctuations again.

UOB has moved in the funding markets, pricing S$850 million of 3% perpetual capital securities under its global medium-term note programme, according to a company announcement. The issue date is set for Jan 21. These securities are callable starting in 2033 and will reset every seven years based on a spread over the seven-year Singapore Overnight Rate Average OIS, a swap benchmark tied to overnight rates.

Perpetual capital securities, known as Additional Tier 1 or AT1, occupy a space between debt and equity. These instruments lack a fixed maturity date, and banks can suspend payouts under specific circumstances. As a result, investors see them as a riskier form of funding despite often modest headline coupons.

But the stock isn’t just riding on buybacks. UOB’s fate still hinges on the usual banking factors: interest rate trends, loan demand, and credit costs. Should benchmark rates drop quicker than anticipated, lending margins could shrink, while any slowdown in the regional economy would put asset quality under pressure.

Investors should watch for Feb 24, the day UOB is set to publish its full-year 2025 results ahead of market open, per a filing with the Singapore Exchange.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Neurocrine Biosciences (NBIX) Stock Fair Value and Performance in Focus
    July 19, 2026, 3:59 PM EDT. Neurocrine Biosciences (NBIX) is viewed as near fairly valued, with shares trading at a P/E ratio of 25.7x versus a fair value estimate of 26.0x. The stock has increased 73.4% over five years and posted a 29.4% gain in the past year, though this trails some competitors. Valuation signals are mixed, with about half indicating the stock could be expensive. Investors are assessing the resilience of cash flows from current therapies alongside operational risks. Growth prospects are supported by a broad pipeline, including late-stage assets and early commercial progress, yet policy changes and concentration risks are present. The overall assessment shows a valuation that reflects tempered expectations for Neurocrine's earnings potential and profitability.
Semiconductor stocks rally as TSMC lifts 2026 capex to $56 billion; ASML hits $500 billion mark
Previous Story

Semiconductor stocks rally as TSMC lifts 2026 capex to $56 billion; ASML hits $500 billion mark

Singapore Airlines stock price: Air India pact in focus after C6L closes at S$6.35
Next Story

Singapore Airlines stock price: Air India pact in focus after C6L closes at S$6.35

Go toTop